Page 934 - Cote clinical veterinary advisor dogs and cats 4th
P. 934

458   Hepatopathy, Copper-Associated


           •  Laparoscopic  biopsies  are  preferred  over   Technician Tips     SUGGESTED READING
            needle biopsies due to the larger tissue sample   •  Avoid jugular venipuncture until coagulation   Dirksen K, et al: Sensitivity and specificity of plasma
  VetBooks.ir  Prevention                     •  Blood  for  bile  acids  is  collected  after  a   Retrievers.  J  Vet  Intern  Med  31(4):1017-1027,
                                                is assessed as normal.
            obtained.
                                                                                   ALT, ALP, and bile acids for hepatitis in Labrador
                                                12-hour fast (preprandial) and 2 hours after
                                                                                   2017.
           Avoid prolonged use of glucocorticoids when
           possible.                            feeding a fatty meal (postprandial).  AUTHOR: Julie E. Trzil, DVM, MS, DACVIM
                                                                                 EDITOR: Leah A. Cohn, DVM, PhD, DACVIM




            Hepatopathy, Copper-Associated                                                         Client Education
                                                                                                         Sheet


            BASIC INFORMATION                   ○   In Bedlingtons, a defect in the COMMD1   Advanced or Confirmatory Testing
                                                  gene leads to decreased biliary excretion   Determination of hepatic copper concentra-
           Definition                             of copper.                     tion: quantitative analysis on hepatic wedge
           Accumulation of copper within hepatocytes,   ○   Genetic basis for copper accumulation   or needle biopsies, digital image analysis of
           leading to hepatotoxicosis             in  other  breeds  is  unknown,  but  some   scanned rhodanine-stained histopathology slides;
                                                  evidence for mutation in ATP7B (a copper   qualitative and semiquantitative assessment of
           Epidemiology                           transporter) in Labradors      rhodamine- or rubeanic acid–stained slides
           SPECIES, AGE, SEX                  •  Secondary  copper  accumulation  is  due  to   •  Normal hepatic copper levels: 200-400 mcg/g
           •  Dogs: common; copper accumulates slowly, and   cholestatic disease and impairment in biliary   dry weight (DW) in dog and < 190 mcg/g
            clinical signs typically appear in middle age  excretion. This is a rare cause of copper   DW in cats
           •  Cats: rare, younger (median age, 2 years)  accumulation in the dog but occurs in cats.  •  In  Bedlingtons,  genetic  test,  microsatellite
                                              •  Emerging evidence suggests that many dogs   marker (C04107) available, but may miss disease
           GENETICS, BREED PREDISPOSITION       accumulate excess copper in the liver associ-  in some pedigrees (5%-10% false-negatives).
           •  Autosomal recessive in Bedlington terriers  ated with excess dietary copper content.  No test for COMMD1 mutation is available.
           •  Predisposition in Dalmatians, West Highland   •  Accumulating copper puts oxidant stress on   •  In  Bedlingtons,  copper  levels  gradually
            white terriers, Labrador retrievers, Doberman   the liver, predisposing it to damage.  increase with age and can reach very high
            pinschers and standard poodles    •  Excess  copper  damages  hepatocytes  by   levels (>10,000 mcg/g DW).
           •  Can  happen  sporadically  in  any  breed  of   inducing the formation of free radicals.  •  Lower copper levels (500-2000 mcg/g DW)
            dog or cat                        •  Rarely, copper storage hepatopathy is associ-  typically occur in Labradors and Dobermans.
                                                ated with renal Fanconi syndrome (p. 322).  •  Cats > 700 mcg/g DW is consistent with
           Clinical Presentation                                                   primary copper hepatopathy.
           DISEASE FORMS/SUBTYPES              DIAGNOSIS                         Histopathologic findings:
           •  Subclinical                                                        •  Inborn errors such as occur in Bedlingtons:
           •  Chronic hepatitis/cirrhosis     Diagnostic Overview                  initial finding is centrilobular copper accumu-
           •  Acute liver disease with hemolytic anemia   The disorder may be suspected in two contexts:   lation with hepatocellular vacuolation, followed
            (rare)                            as part of any necroinflammatory or cholestatic   by degeneration/necrosis and then inflamma-
                                              liver disease (detected as part of evaluation   tion and fibrosis; progresses to become more
           HISTORY, CHIEF COMPLAINT           of liver biopsy specimens) or in cases where   panlobular with periportal orientation
           •  Patients  usually  present  with  features  of   copper accumulation is the dominant feature of   •  In secondary copper accumulation, copper
            chronic hepatic disease such as polyuria and   hepatopathy in a dog (e.g., Bedlington terrier)   staining is located primarily in areas of
            polydipsia, lethargy, vomiting, abdominal   with or without overt clinical signs. Definitive   inflammation or degeneration (periportal),
            distention, or encephalopathy (p. 440) or,   diagnosis requires quantification of hepatic   with more accumulation in macrophages.
            less commonly, with acute liver failure (p.   copper content from a liver biopsy specimen.  •  Cats with primary copper hepatopathy are pre-
            442) and hemolytic anemia (p. 59).                                     disposed to develop hepatocellular carcinoma.
           •  In early stages, patients may be asymptomatic   Differential Diagnosis
            with just increased serum liver enzyme   Chronic:                     TREATMENT
            activities,  particularly  serum  alanine  ami-  •  Infectious,  immune,  or  toxic  causes  of
            notransferase (ALT).                inflammatory hepatic disease     Treatment Overview
                                              •  Hepatic neoplasia               Decrease hepatic copper concentration, decrease
           Etiology and Pathophysiology       •  Congenital portosystemic shunts  copper absorption, and attenuate oxidant injury
           •  Copper  is  absorbed  in  the  small  intestine   Acute:
            and extracted by hepatocytes. Copper is   •  Infectious, immune, drug, or toxin-induced   Acute General Treatment
            chaperoned around the hepatocyte before   (zinc) hemolytic anemia    Manage the complications of acute or chronic
            being released into the serum or excreted in   •  Exposure to hepatotoxic drugs or environ-  hepatic disease (pp. 174 and 452).
            bile. A small amount is stored in lysosomes.  mental toxins
           •  Copper homeostasis is maintained by biliary   •  Infectious canine hepatitis, leptospirosis  Chronic Treatment
            excretion of excess copper.                                          In dogs other than Bedlingtons and Dalmatians,
           •  Abnormal  hepatic  copper  accumulation   Initial Database         the need to treat elevated hepatic copper
            occurs because of a primary inborn error of   Tests to rule out hemolytic anemia (p. 59),   concentrations is based on distribution of the
            metabolism or secondary to increased dietary   cirrhotic/fibrosing liver disease (p. 174), acute   copper in the biopsy, the presence of concurrent
            consumption or acquired cholestatic liver   hepatic injury (p. 442), and chronic idiopathic   liver injury or inflammation, and evaluation
            disease.                          hepatitis (p. 452)                 of clinicopathologic markers of liver injury.
                                                     www.ExpertConsult.com
   929   930   931   932   933   934   935   936   937   938   939